1. Home
  2. NRXP vs LXEH Comparison

NRXP vs LXEH Comparison

Compare NRXP & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • LXEH
  • Stock Information
  • Founded
  • NRXP 2015
  • LXEH 2001
  • Country
  • NRXP United States
  • LXEH China
  • Employees
  • NRXP N/A
  • LXEH N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • LXEH Other Consumer Services
  • Sector
  • NRXP Health Care
  • LXEH Real Estate
  • Exchange
  • NRXP Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • NRXP 58.5M
  • LXEH 55.2M
  • IPO Year
  • NRXP N/A
  • LXEH 2020
  • Fundamental
  • Price
  • NRXP $2.84
  • LXEH $2.19
  • Analyst Decision
  • NRXP Strong Buy
  • LXEH
  • Analyst Count
  • NRXP 5
  • LXEH 0
  • Target Price
  • NRXP $31.40
  • LXEH N/A
  • AVG Volume (30 Days)
  • NRXP 562.9K
  • LXEH 3.0M
  • Earning Date
  • NRXP 08-18-2025
  • LXEH 09-26-2025
  • Dividend Yield
  • NRXP N/A
  • LXEH N/A
  • EPS Growth
  • NRXP N/A
  • LXEH N/A
  • EPS
  • NRXP N/A
  • LXEH N/A
  • Revenue
  • NRXP N/A
  • LXEH $4,493,795.00
  • Revenue This Year
  • NRXP N/A
  • LXEH N/A
  • Revenue Next Year
  • NRXP $231.16
  • LXEH N/A
  • P/E Ratio
  • NRXP N/A
  • LXEH N/A
  • Revenue Growth
  • NRXP N/A
  • LXEH N/A
  • 52 Week Low
  • NRXP $1.10
  • LXEH $1.12
  • 52 Week High
  • NRXP $6.01
  • LXEH $50.08
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 56.21
  • LXEH 61.01
  • Support Level
  • NRXP $2.26
  • LXEH $1.80
  • Resistance Level
  • NRXP $2.81
  • LXEH $2.05
  • Average True Range (ATR)
  • NRXP 0.23
  • LXEH 0.16
  • MACD
  • NRXP 0.04
  • LXEH 0.07
  • Stochastic Oscillator
  • NRXP 78.38
  • LXEH 94.55

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: